Literature DB >> 24055740

Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies.

Peter Würtz1, Antti J Kangas, Pasi Soininen, Terho Lehtimäki, Mika Kähönen, Jorma S Viikari, Olli T Raitakari, Marjo-Riitta Järvelin, George Davey Smith, Mika Ala-Korpela.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24055740     DOI: 10.1016/j.jacc.2013.07.085

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  24 in total

Review 1.  Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.

Authors:  M F Hivert; W Perng; S M Watkins; C S Newgard; L C Kenny; B S Kristal; M E Patti; E Isganaitis; D L DeMeo; E Oken; M W Gillman
Journal:  J Dev Orig Health Dis       Date:  2015-01-29       Impact factor: 2.401

Review 2.  Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.

Authors:  Stephen Burgess; Eric Harshfield
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

3.  Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.

Authors:  Stephen Burgess; Simon G Thompson
Journal:  Am J Epidemiol       Date:  2015-01-27       Impact factor: 4.897

4.  Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.

Authors:  Stephen Burgess; Robert A Scott; Nicholas J Timpson; George Davey Smith; Simon G Thompson
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

5.  Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.

Authors:  Anna Helgadottir; Solveig Gretarsdottir; Gudmar Thorleifsson; Eirikur Hjartarson; Asgeir Sigurdsson; Audur Magnusdottir; Aslaug Jonasdottir; Helgi Kristjansson; Patrick Sulem; Asmundur Oddsson; Gardar Sveinbjornsson; Valgerdur Steinthorsdottir; Thorunn Rafnar; Gisli Masson; Ingileif Jonsdottir; Isleifur Olafsson; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Maryam S Daneshpour; Davood Khalili; Fereidoun Azizi; Dorine W Swinkels; Lambertus Kiemeney; Arshed A Quyyumi; Allan I Levey; Riyaz S Patel; Salim S Hayek; Ingibjorg J Gudmundsdottir; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hilma Holm; Kari Stefansson
Journal:  Nat Genet       Date:  2016-05-02       Impact factor: 41.307

6.  Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity.

Authors:  Sophie Schutte; Diederik Esser; Els Siebelink; Charlotte J R Michielsen; Monique Daanje; Juri C Matualatupauw; Hendriek C Boshuizen; Marco Mensink; Lydia A Afman
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

7.  Mendelian randomization of blood lipids for coronary heart disease.

Authors:  Michael V Holmes; Folkert W Asselbergs; Tom M Palmer; Fotios Drenos; Matthew B Lanktree; Christopher P Nelson; Caroline E Dale; Sandosh Padmanabhan; Chris Finan; Daniel I Swerdlow; Vinicius Tragante; Erik P A van Iperen; Suthesh Sivapalaratnam; Sonia Shah; Clara C Elbers; Tina Shah; Jorgen Engmann; Claudia Giambartolomei; Jon White; Delilah Zabaneh; Reecha Sofat; Stela McLachlan; Pieter A Doevendans; Anthony J Balmforth; Alistair S Hall; Kari E North; Berta Almoguera; Ron C Hoogeveen; Mary Cushman; Myriam Fornage; Sanjay R Patel; Susan Redline; David S Siscovick; Michael Y Tsai; Konrad J Karczewski; Marten H Hofker; W Monique Verschuren; Michiel L Bots; Yvonne T van der Schouw; Olle Melander; Anna F Dominiczak; Richard Morris; Yoav Ben-Shlomo; Jackie Price; Meena Kumari; Jens Baumert; Annette Peters; Barbara Thorand; Wolfgang Koenig; Tom R Gaunt; Steve E Humphries; Robert Clarke; Hugh Watkins; Martin Farrall; James G Wilson; Stephen S Rich; Paul I W de Bakker; Leslie A Lange; George Davey Smith; Alex P Reiner; Philippa J Talmud; Mika Kivimäki; Debbie A Lawlor; Frank Dudbridge; Nilesh J Samani; Brendan J Keating; Aroon D Hingorani; Juan P Casas
Journal:  Eur Heart J       Date:  2014-01-27       Impact factor: 29.983

8.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.

Authors:  Neil M Davies; Tom R Gaunt; Sarah J Lewis; Jeff Holly; Jenny L Donovan; Freddie C Hamdy; John P Kemp; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Fredrik Wiklund; Henrik Gronberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; David Neal; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Hardev Pandha; Mark Lathrop; George Davey Smith; Richard M Martin
Journal:  Cancer Causes Control       Date:  2015-09-19       Impact factor: 2.506

9.  Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Arif A Khokhar; Joseph M Massaro; Seth T Lirette; Michael E Griswold; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Adolfo Correa; Ralph B D'Agostino; Steven R Jones; Peter P Toth
Journal:  J Am Heart Assoc       Date:  2016-04-29       Impact factor: 5.501

10.  Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.

Authors:  Stephen Burgess; Daniel F Freitag; Hassan Khan; Donal N Gorman; Simon G Thompson
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.